Skip to main content
SBRA
NASDAQ Real Estate & Construction

Sabra Health Care REIT Reports Strong 2025 Financials, Strategic Portfolio Growth, and Favorable Regulatory Changes

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$19.6
Mkt Cap
$4.887B
52W Low
$15.595
52W High
$20.27
Market data snapshot near publication time

summarizeSummary

Sabra Health Care REIT reported robust financial results for 2025, driven by strategic acquisitions, improved operational performance, and a significant regulatory tailwind from the repeal of nurse staffing standards.


check_boxKey Events

  • Strong Financial Performance

    Net income attributable to Sabra Health Care REIT, Inc. increased to $155.6 million in 2025 from $126.7 million in 2024. FFO per diluted common share rose to $1.48 from $1.36, and AFFO per diluted common share increased to $1.47 from $1.43 year-over-year.

  • Strategic Portfolio Expansion and Optimization

    The company acquired 11 Senior Housing - Managed communities and 24 additional units for an aggregate of $434.5 million. Concurrently, it disposed of 15 facilities (14 skilled nursing/transitional care and 1 behavioral health) for $88.5 million, as part of its capital recycling initiative.

  • Successful Debt Refinancing

    Sabra redeemed all $500.0 million of its 5.125% senior unsecured notes due 2026 and secured a new $500.0 million U.S. dollar term loan maturing in July 2030, effectively extending its debt maturity profile.

  • Favorable Regulatory Development

    CMS repealed the minimum nurse staffing requirements for long-term care facilities, effective February 2, 2026, reducing a significant operational burden for healthcare operators. Additionally, Medicare rates for skilled nursing facilities are projected to increase by 3.2% for fiscal year 2026.


auto_awesomeAnalysis

Sabra Health Care REIT's 2025 annual report highlights a period of strong financial performance and strategic operational advancements. The company achieved significant increases in net income, FFO, and AFFO per diluted share, demonstrating improved profitability. Key drivers included growth in resident fees and services, reduced real estate impairment charges, and a notable turnaround in income from unconsolidated joint ventures. The company also successfully refinanced $500 million in senior unsecured notes due 2026 with a new term loan maturing in 2030, enhancing its debt maturity profile. Strategic capital recycling efforts continued with substantial acquisitions and dispositions aimed at optimizing the portfolio. Furthermore, the repeal of the CMS minimum nurse staffing standards, effective February 2, 2026, represents a significant positive regulatory development for the healthcare real estate sector, potentially easing operational burdens for Sabra's tenants and managed communities. This comprehensive report underscores a positive trajectory for the company, supported by robust liquidity and proactive management.

At the time of this filing, SBRA was trading at $19.60 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $4.9B. The 52-week trading range was $15.60 to $20.27. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SBRA - Latest Insights

SBRA
Apr 29, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
SBRA
Feb 12, 2026, 4:07 PM EST
Filing Type: 10-K
Importance Score:
8
SBRA
Feb 12, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7